Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

After seeing several similar omissions I have concluded that your powers-that-be allow this as long as there is sufficient information available for a change diligent reader to do the 'crucial' calculations. BTW: IPIX not reporting numbers for cisplatin weekly schedule is not nearly the most appalling. How would you react to finding out about omission in FDA label risking some patients of not so diligent doctors (my bet: a fair majority) with surprise shortened life (situation since corrected in NCCN treatment guidelines but not in FDA label).

I have said before that even in such small field as oral mucositis IPIX is not alone.
1. Soligenix did the IPIX thing with a twist of messed group headcounts in peer reviewed publication adding to the degree of difficulty.
2. There is enough fudge oozing from Galera's "per IIT" numbers to make it impossible to reconcile which 'per protocol' group was actually used to calculate the reported percentages beyond this observation:" It ain't your usual ITT."